A dose ‐finding study of the checkpoint kinase 1 inhibitor, prexasertib, in Japanese patients with advanced solid tumors

Cancer Science,Volume 0, Issue ja, -Not available-.

Source: Cancer Science - July 24, 2018 Category: Cancer & Oncology Authors: Satoru Iwasa , Noboru Yamamoto , Kohei Shitara , Kenji Tamura , Nobuaki Matsubara , Masaomi Tajimi , Aimee Bence Lin , Hiroya Asou , Zhihong Cai , Koichi Inoue , Yuko Shibasaki , Kanako Saito , Hiroki Takai , Toshihiko Doi Source Type: research